228 related articles for article (PubMed ID: 34358075)
1. Protective Effects of Irbesartan, an Angiotensin Receptor Blocker with PPARγ Agonistic Activity, against Estradiol Benzoate-Induced Endometrial Hyperplasia and Atypia in Female Rats via Modulation of TNFα/Survivin Pathway.
Morsy MA; Abdelraheem WM; El-Hussieny M; Refaie MMM
Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358075
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-1b and its antagonist (diacerein) in estradiol benzoate-induced endometrial hyperplasia and atypia in female rats.
Refaie MMM; El-Hussieny M
Fundam Clin Pharmacol; 2017 Aug; 31(4):438-446. PubMed ID: 28299811
[TBL] [Abstract][Full Text] [Related]
3. Chloroform Fraction of
Olowofolahan AO; Akinjiola O; Olanlokun JO; Oyebode OT; Aina OO; Olorunsogo OO
Anticancer Agents Med Chem; 2023; 23(11):1298-1308. PubMed ID: 36757042
[TBL] [Abstract][Full Text] [Related]
4. Methyl palmitate reversed estradiol benzoate-induced endometrial hyperplasia in female rats.
Olowofolahan AO; Oyebode OT; Olorunsogo OO
Toxicol Mech Methods; 2021 Jan; 31(1):43-52. PubMed ID: 32967526
[TBL] [Abstract][Full Text] [Related]
5. Irbesartan, an angiotensin II receptor antagonist, with selective PPAR-gamma-modulating activity improves function and structure of chemotherapy-damaged ovaries in rats.
Abdel-Raheem IT; Omran GA; Katary MA
Fundam Clin Pharmacol; 2015 Jun; 29(3):286-98. PubMed ID: 25824615
[TBL] [Abstract][Full Text] [Related]
6. PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats.
Mohamed MZ; Baky MAE; Hassan OA; Mohammed HH; Abdel-Aziz AM
Hum Exp Toxicol; 2020 Sep; 39(9):1224-1234. PubMed ID: 32228192
[TBL] [Abstract][Full Text] [Related]
7. Melatonin reduced endometrial hyperplasia induced by estradiol in female albino rats.
Abdel-Hamid HA; Zenhom NM; Toni ND
Gen Physiol Biophys; 2019 Jan; 38(1):63-71. PubMed ID: 30657459
[TBL] [Abstract][Full Text] [Related]
8. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia.
Kubyshkin AV; Aliev LL; Fomochkina II; Kovalenko YP; Litvinova SV; Filonenko TG; Lomakin NV; Kubyshkin VA; Karapetian OV
Inflamm Res; 2016 Oct; 65(10):785-94. PubMed ID: 27312112
[TBL] [Abstract][Full Text] [Related]
9. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
El-Said NT; Mohamed EA; Taha RA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Dalla Libera L; Ravara B; Angelini A; Rossini K; Sandri M; Thiene G; Battista Ambrosio G; Vescovo G
Circulation; 2001 May; 103(17):2195-200. PubMed ID: 11331262
[TBL] [Abstract][Full Text] [Related]
11. Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.
Chatterjee A; Kusunoki H; Taniyama Y; Rakugi H; Morishita R
Biomed Rep; 2013 Jan; 1(1):65-70. PubMed ID: 24648895
[TBL] [Abstract][Full Text] [Related]
12. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
Ibrahim MA; Amin EF; Ibrahim SA; Abdelzaher WY; Abdelrahman AM
Eur J Pharmacol; 2014 Feb; 724():204-10. PubMed ID: 24370493
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the protective effect of montelukast in prevention of endometrial hyperplasia in female rats.
Abdelzaher WY; Bahaa HA; Toni NDM; Sanad AS
Int Immunopharmacol; 2018 Sep; 62():326-333. PubMed ID: 30056375
[TBL] [Abstract][Full Text] [Related]
14. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of irbesartan against doxorubicin-induced nephrotoxicity in rats: implication of AMPK, PI3K/Akt, and mTOR signaling pathways.
Mohamed EA; Ahmed HI; Zaky HS
Can J Physiol Pharmacol; 2018 Dec; 96(12):1209-1217. PubMed ID: 30351976
[TBL] [Abstract][Full Text] [Related]
16. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
Jing L; Li WM; Zhou LJ; Li S; Kou JJ; Song J
Alcohol Clin Exp Res; 2008 Nov; 32(11):1999-2007. PubMed ID: 18783396
[TBL] [Abstract][Full Text] [Related]
17. Irbesartan mitigates acute liver injury, oxidative stress, and apoptosis induced by acetaminophen in mice.
Helal MG; Samra YA
J Biochem Mol Toxicol; 2020 Dec; 34(12):e22447. PubMed ID: 31967706
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of estrogen-induced endometrial hyperplasia in female rats by hemin via heme-oxygenase-1 expression, suppression of iNOS, p38 MAPK, and Ki67.
Ali FF; Abdelzaher WY; Ibrahim RA; Elroby Ali DM
Can J Physiol Pharmacol; 2019 Dec; 97(12):1159-1168. PubMed ID: 31505119
[TBL] [Abstract][Full Text] [Related]
19. Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats.
Elshazly SM; Abd El Motteleb DM; Ibrahim IAAE
Chem Biol Interact; 2018 Aug; 291():153-161. PubMed ID: 29944876
[TBL] [Abstract][Full Text] [Related]
20. Diacerein inhibits Estradiol-benzoate induced cervical hyperkeratosis in female rats.
Refaie MMM; El-Hussieny M
Biomed Pharmacother; 2017 Nov; 95():223-229. PubMed ID: 28843910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
